Astrazeneca (AZN) Interest Coverage Ratio (2009 - 2026)
Astrazeneca (AZN) posted quarterly Interest Coverage Ratio of 7.27 for Q2 2026, down 8.98% year-over-year from 7.99 in Q2 2025, and up 175.55% quarter-over-quarter from 9.63 in Q1 2026.
Astrazeneca (AZN) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Astrazeneca's Interest Coverage Ratio history runs 18 years deep, the most recent figure standing at 7.27 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio fell 8.98% year-over-year to 7.27; the TTM figure through Jun 2026 stood at 15.47 (up 540.9% YoY), while the FY2025 annual figure was 8.11, up 41.28% from the prior year.
- Interest Coverage Ratio for Q2 2026 stood at 7.27, up from 9.63 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 7.99 in Q2 2025, with the low at 9.92 in Q1 2023.
- The 5-year median for Interest Coverage Ratio is 2.8 (2022), against an average of 2.0.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio sank 882.99% in 2022, then soared 228.79% in 2023.
- Astrazeneca's Interest Coverage Ratio stood at 4.38 in 2022, then tumbled by 46.98% to 6.44 in 2023, then soared by 75.91% to 1.55 in 2024, then jumped by 169.51% to 1.08 in 2025, then jumped by 574.84% to 7.27 in 2026.
- Business Quant data shows AZN's Interest Coverage Ratio at 7.27 in Q2 2026, 9.63 in Q1 2026, and 1.08 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.81 Bn | 633.06 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 469.85 Bn | 463.28 Bn | 12.70 Bn | - |
| 3 | Merck | 375.13 Bn | 367.99 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 302.67 Bn | 294.98 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 257.60 Bn | 252.70 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 237.08 Bn | 223.09 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 183.35 Bn | 180.18 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 160.17 Bn | 148.47 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.99 Bn | 101.83 Bn | 8.24 Bn | -2.64 |
| 10 | Sanofi | 55.21 Bn | 47.83 Bn | 10.79 Bn | -50.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.27 |
| Mar 31, 2026 | -9.63 |
| Dec 31, 2025 | 1.08 |
| Sep 30, 2025 | -1.93 |
| Jun 30, 2025 | 7.99 |
| Mar 31, 2025 | -8.71 |
| Dec 31, 2024 | -1.55 |
| Sep 30, 2024 | -1.09 |
| Jun 30, 2024 | 6.20 |
| Mar 31, 2024 | -9.13 |
| Dec 31, 2023 | -6.44 |
| Sep 30, 2023 | -4.98 |
| Jun 30, 2023 | 5.70 |
| Mar 31, 2023 | -9.92 |
| Dec 31, 2022 | -4.38 |
| Sep 30, 2022 | -3.67 |
| Jun 30, 2022 | 1.73 |
| Mar 31, 2022 | -4.53 |
| Dec 31, 2021 | 0.56 |
| Sep 30, 2021 | 8.41 |